ArticleOpen veterinary journal2024
Molecular characterization of Newcastle disease virus (AOAV-1) obtained from Western region of Libya.
Article in Open veterinary journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Terminal V5 Tagging of All Four Newcastle Disease Virus Structural Proteins Is Compatible with Particle Formation in Sf9 Cells.International journal of molecular sciences · 2026Article
- Genetic Diversity of Newcastle Disease Virus and Its Implications for Vaccine Development.Veterinary sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Since its discovery in 1926, Newcastle disease (ND) is still emerging in many avian species worldwide causing severe economic losses due to high mortality. Aim: This article aims to discuss the challenge of virulent ND in poultry in Libya, focusing on recent outbreaks investigated in Alzintan, Alrayaina, Nalut, and Surman, cities located in the western region of Libya. Methods: Clinical signs and lesions were recorded. Tissues, as well as tracheal and cloacal swabs, were collected. RNA extraction was performed for confirmation using PCR and sequencing. Results: Mortality, in general, reached 50%-100% in vaccinated flocks with respiratory distress, diarrhea, swelling of the face, and nasal discharges. Necropsy revealed severe hemorrhages in the proventriculus, necrosis, and hemorrhages in the intestine and cecal tonsils. All tested samples were positive for avian orthoavulavirus 1 (AOAV-1) using rRT-PCR and genetic analysis. The sequences obtained are referable to AOAV-1, which is the same strain in all tested samples. The amino acid sequences deduced from the cleavage site of the Conclusion: ND remains a significant threat to the poultry industry in Libya. Therefore, there is an urgent need to conduct an epidemiological study with a representative number of samples from all regions of the country, alongside the implementation of an inactivated vaccine targeting genotype VII.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.